<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Le Chapelain O</submitter><funding>INCA</funding><funding>ANR</funding><funding>La fondation Arc</funding><pagination>84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10944607</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>How platelets interact with and influence the tumor microenvironment (TME) remains poorly characterized.&lt;h4>Methods&lt;/h4>We compared the presence and participation of platelets in the TME of two tumors characterized by highly different TME, PyMT AT-3 mammary tumors and B16F1 melanoma.&lt;h4>Results&lt;/h4>We show that whereas firmly adherent platelets continuously line tumor vessels of both AT-3 and B16F1 tumors, abundant extravascular stromal clusters of platelets from thrombopoietin-independent origin were present only in AT-3 mammary tumors. We further show that platelets influence the angiogenic and inflammatory profiles of AT-3 and B16F1 tumors, though with very different outcomes according to tumor type. Whereas thrombocytopenia increased bleeding in both tumor types, it </pubmed_abstract><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pubmed_title>The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependent.</pubmed_title><pmcid>PMC10944607</pmcid><funding_grant_id>RPT16002MMA</funding_grant_id><funding_grant_id>ANR-18-RHUS-0001</funding_grant_id><funding_grant_id>PJA 20151203107</funding_grant_id><pubmed_authors>Solo Nomenjanahary M</pubmed_authors><pubmed_authors>Boulaftali Y</pubmed_authors><pubmed_authors>Jadoui S</pubmed_authors><pubmed_authors>Ho-Tin-Noe B</pubmed_authors><pubmed_authors>Barbaria S</pubmed_authors><pubmed_authors>Delbosc S</pubmed_authors><pubmed_authors>Caligiuri G</pubmed_authors><pubmed_authors>Benmeziane K</pubmed_authors><pubmed_authors>Nieswandt B</pubmed_authors><pubmed_authors>Rogozarski J</pubmed_authors><pubmed_authors>Gros A</pubmed_authors><pubmed_authors>Mangin PH</pubmed_authors><pubmed_authors>Mawhin MA</pubmed_authors><pubmed_authors>Ollivier V</pubmed_authors><pubmed_authors>Le Chapelain O</pubmed_authors><pubmed_authors>Mavouna S</pubmed_authors><pubmed_authors>Porteu F</pubmed_authors><pubmed_authors>Dupont S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependent.</name><description>&lt;h4>Background&lt;/h4>How platelets interact with and influence the tumor microenvironment (TME) remains poorly characterized.&lt;h4>Methods&lt;/h4>We compared the presence and participation of platelets in the TME of two tumors characterized by highly different TME, PyMT AT-3 mammary tumors and B16F1 melanoma.&lt;h4>Results&lt;/h4>We show that whereas firmly adherent platelets continuously line tumor vessels of both AT-3 and B16F1 tumors, abundant extravascular stromal clusters of platelets from thrombopoietin-independent origin were present only in AT-3 mammary tumors. We further show that platelets influence the angiogenic and inflammatory profiles of AT-3 and B16F1 tumors, though with very different outcomes according to tumor type. Whereas thrombocytopenia increased bleeding in both tumor types, it </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-20T02:52:37.001Z</modification><creation>2025-04-20T02:52:37.001Z</creation></dates><accession>S-EPMC10944607</accession><cross_references><pubmed>38493157</pubmed><doi>10.1186/s13046-024-03001-2</doi></cross_references></HashMap>